What if we could diagnose risk for Alzheimer’s before symptoms appeared? To address the challenge, in the Laboratory of Neurosciences at the IRP, Dr. Maja Mustapic searches for Alzheimer’s biomarkers using liquid biopsies.
Inspired by September’s World Alzheimer's Awareness Month and driven by my interest in cognitive aging and dementia, I'm asking my fellow IRP postdoctoral researchers about which approaches they believe hold promise for advancing our understanding of Alzheimer’s disease.
Research suggests that two-thirds of U.S. adults drink two or more cups of coffee a day. There are multiple reasons for this, likely because coffee has multiple effects on the body. Consider the standard morning scenario for many people.
The brain’s complexity and how its coordinated actions of billions of neurons shape our behavior and cognition have always fascinated me. So, I decided to go into neuroscience as a career and contribute to biomedical science.